(firstQuint)The Drug-drug Interaction of SP2086 and Simvastatin.

 This is an open-label (volunteers will know the names of treatments they are assigned) single-center and cross-over study of SP2086 and Simvastatin in healthy adult volunteers.

 All subject were randomized into two groups, and the drugs will be administered according to the AB and BA sequences.

 The A sequence was that SP2086 was taken at 40mg qd on Day1-Day 10; Simvastatin will be administered orally (by mouth) as 200mg on Day 6-Day10.

The B sequence was that Simvastatin was taken at 40mg qd on Day6-Day10.

 There were 5 days washout period between A and B.

 The total time of this trial was 27 days.

.

 The Drug-drug Interaction of SP2086 and Simvastatin@highlight

The purpose of the study is to investigate the potential interaction between SP2086 and Simvastatin after the multiple oral doses treatment in healthy adult volunteers.

